Last reviewed 18 January 2021

The Industrial Injuries Advisory Council (IIAC) has announced its intention to carry out a review of selected malignant and non-malignant respiratory diseases and the relationships between occupational exposures.

It will commission a comprehensive review and evaluation of the literature, including epidemiology, on work-related respiratory diseases, primarily focusing on lung cancer and COPD, to inform, update or potentially expand the industrial injuries scheme.

It has invited suitably qualified interested participants, with relevant experience, to explore the feasibility of undertaking a systematic review of the literature on these diseases and current prescriptions.

A systematic approach to evidence gathering and synthesis is required and interested parties should indicate how their proposed methods will ensure robust evaluation.

A two phase approach is anticipated with phase 1 taking around six months and with a further 12 months allowed to complete phase 2 and deliver the final report. A report should also be provided at the end of Phase 1.

The closing date for receipt of expressions of interest is 12pm on 29 January 2021 with full details available at GOV.UK.

It is envisaged that any research undertaken will be used to determine if the current prescribed diseases qualifying for industrial injuries disablement benefit relating to respiratory conditions are fit for purpose and inform recommendations to amend the regulations if necessary.

Those who would like to express an interest in participating in the tender selection process are asked in the first instance to submit their names, email contact details, qualifications and a brief resume (no more than 200 words) to the address given in the above link.